tirzepatide is glp 1 GLP-1 Genetics: How Genes Affect Appetite, Semaglutide, and Response Tirzepatide | GLP1 | Medical

No new or unexpected safety signals emerged with prolonged use, supporting the medical consensus that long-term GLP-1 therapy is appropriate for eligible patients

Adverse Reactions Occasionally, dry mouth or mild gastrointestinal discomfort may occur, which can resolve on its own after discontinuing the medication

Individual timelines vary, but clinical trials show most people experience appetite suppression within the first week and measurable weight loss within 2 to 4 weeks

(5) CJC-1295 (Mod GRF 1-29) peptide has four amino acid substitutions in its structure, which appears to enhance its GH-related activity as well as its potential resistance towards the proteolytic enzymes

Retrieved June 10, 2025, from [ \- Link Opens in New Tab]( 16